Economias de custo

Abordagem sistemática e multimodal

Impact of a patient blood management monitoring and feedback programme on allogeneic blood transfusions and related costs. (abre nova janela)

Kaserer A, Rössler J, Braun J, Farokhzad F, Pape HC, Dutkowski P, Plass A, Horisberger T, Volbracht J, Manz MG, Spahn, DR

Fonte‎: Anaesthesia 2019;74(12):1534-41.

Indexado‎: PubMed 31448406

DOI‎: 10.1111/anae.14816

https://www.ncbi.nlm.nih.gov/pubmed/31448406 (abre nova janela)

Cost-effectiveness of eltrombopag vs intravenous immunoglobulin for the perioperative management of immune thrombocytopenia. (abre nova janela)

Kaur MN, Arnold DM, Heddle NM, Cook RJ, Hsia C, Blostein M, Jamula E, Sholzberg M, Lin Y, Kassis J, Larratt L, Tinmouth A, Carruthers J, Li N, Liu Y, Xie F

Fonte‎: Blood Adv. 2022;6(3):785-92.

Indexado‎: PubMed 34781363

DOI‎: 10.1182/bloodadvances.2021005627

https://pubmed.ncbi.nlm.nih.gov/34781363/ (abre nova janela)

Blood use in patients receiving intensive chemotherapy for acute leukemia or hematopoietic stem cell transplantation: the impact of a health system-wide patient blood management program. (abre nova janela)

Leahy MF, Trentino KM, May C, Swain SG, Chuah H, Farmer SL.

Fonte‎: Transfusion 2017;57(9):2189-96.

Indexado‎: PubMed 28671296

DOI‎: 10.1111/trf.14191

https://www.ncbi.nlm.nih.gov/pubmed/28671296 (abre nova janela)

Implementation of a patient blood management monitoring and feedback program significantly reduces transfusions and costs. (abre nova janela)

Mehra T, Seifert B, Bravo-Reiter S, Wanner G, Dutkowski P, Holubec T, Moos RM, Volbracht J, Manz MG, Spahn DR

Fonte‎: Transfusion 2015;55(12):2807-15.

Indexado‎: PubMed 26264557

DOI‎: 10.1111/trf.13260

https://www.ncbi.nlm.nih.gov/pubmed/26264557 (abre nova janela)

Prospective monitoring of plasma and platelet transfusions in a large teaching hospital results in significant cost reduction. (abre nova janela)

Sarode R, Refaai MA, Matevosyan K, Burner JD, Hampton S, Rutherford C.

Fonte‎: Transfusion 2010;50(2):487-92.

Indexado‎: PubMed 19804569

DOI‎: 10.1111/j.1537-2995.2009.02413.x

https://www.ncbi.nlm.nih.gov/pubmed/19804569 (abre nova janela)

Anemia Management

Should intravenous iron be the standard of care in oncology? (abre nova janela)

Auerbach M.

Fonte‎: J Clin Oncol 2008;26(10):1579-81.

Indexado‎: PubMed 18375888

DOI‎: 10.1200/JCO.2007.15.4609

https://www.ncbi.nlm.nih.gov/pubmed/18375888 (abre nova janela)

Early intravenous iron administration in the Emergency Department reduces red blood cell unit transfusion, hospitalisation, re-transfusion, length of stay and costs. (abre nova janela)

Beverina I, Razionale G, Ranzini M, Aloni A, Finazzi S, Brando B.

Fonte‎: Blood Transfus 2020;18(2):106-16.

Indexado‎: PubMed 31855149

DOI‎: 10.2450/2019.0248-19

https://www.ncbi.nlm.nih.gov/pubmed/31855149 (abre nova janela)

The cost-effectiveness of treatment with erythropoietin compared to red blood cell transfusions for patients with chemotherapy induced anaemia: a Markov model. (abre nova janela)

Borg S, Glenngård AH, Osterborg A, Persson U.

Fonte‎: Acta Oncol 2008;47(6):1009-17.

Indexado‎: PubMed 18770060

DOI‎: 10.1080/02841860701744498

https://www.ncbi.nlm.nih.gov/pubmed/18770060 (abre nova janela)

Hemoglobin level at initiation of darbepoetin alfa: impact on need for transfusion and associated costs in chemotherapy-induced anemia treatment in Europe. (abre nova janela)

Deger M, Eisterer W, Kutikova L, Salek S.

Fonte‎: Support Care Cancer 2013;21(2):485-93.

Indexado‎: PubMed 22825456

DOI‎: 10.1007/s00520-012-1538-0

https://www.ncbi.nlm.nih.gov/pubmed/22825456 (abre nova janela)

Prospective study of erythropoietin use on quality of life and cost effectiveness in acute myeloid leukemia and allogeneic hematopoietic stem cell transplantation patients. (abre nova janela)

Michallet M, Goldet K, Sobh M, Morisset S, Chelghoum Y, Thomas X, Barraco F, Ducastelle S, Labussière H, Renzullo C, Paillet C, Pivot C, Straaten PB, Denis A, Termoz A, Detrait M, Nicolini FE, Jaisson-Hot I.

Fonte‎: Cancer 2013;119(1):107-14.

Indexado‎: PubMed 22744794

DOI‎: 10.1002/cncr.27686

https://www.ncbi.nlm.nih.gov/pubmed/22744794 (abre nova janela)

Budget impact analysis on erythropoiesis-stimulating agents use for the management of chemotherapy-induced anaemia in Greece. (abre nova janela)

Nikolaidi E, Hatzikou M, Geitona M.

Fonte‎: Cost Eff Resour Alloc 2013;11(1):16.

Indexado‎: PubMed 23870502

DOI‎: 10.1186/1478-7547-11-16

https://www.ncbi.nlm.nih.gov/pubmed/23870502 (abre nova janela)

Outcomes of erythropoiesis-stimulating agents in cancer patients with chemotherapy-induced anemia. (abre nova janela)

Pashos CL, Larholt K, Fraser KA, McKenzie RS, Senbetta M, Piech CT.

Fonte‎: Support Care Cancer 2012;20(1):159-65.

Indexado‎: PubMed 21359879

DOI‎: 10.1007/s00520-010-1083-7

https://www.ncbi.nlm.nih.gov/pubmed/21359879 (abre nova janela)

Agentes hemostáticos

Modeling the cost-effectiveness of prothrombin complex concentrate compared with fresh frozen plasma in emergency warfarin reversal in the United Kingdom. (abre nova janela)

Guest JF, Watson HG, Limaye S.

Fonte‎: Clin Ther 2010;32(14):2478-93.

Indexado‎: PubMed 21353116

DOI‎: 10.1016/j.clinthera.2011.01.011

https://www.ncbi.nlm.nih.gov/pubmed/21353116 (abre nova janela)

Recombinant activated factor VII use in critically ill infants with active hemorrhage. (abre nova janela)

Jen H, Shew S.

Fonte‎: J Pediatr Surg 2008;43(12):2235-8.

Indexado‎: PubMed 19040942

DOI‎: 10.1016/j.jpedsurg.2008.08.053

https://www.ncbi.nlm.nih.gov/pubmed/19040942 (abre nova janela)

Manejo do sangue e conservação do sangue intraoperatório/periprocedimento

Restrictive blood transfusion practices are associated with improved patient outcomes. (abre nova janela)

Goodnough LT, Maggio P, Hadhazy E, Shieh L, Hernandez-Boussard T, Khari P, Shah N.

Fonte‎: Transfusion 2014;54(10 Pt 2):2753-9.

Indexado‎: PubMed 24995770

DOI‎: 10.1111/trf.12723

https://www.ncbi.nlm.nih.gov/pubmed/24995770 (abre nova janela)

Blood transfusion versus hydroxyurea in beta-thalassemia in Iran: a cost-effectiveness study. (abre nova janela)

Ravangard R, Mirzaei Z, Keshavarz K, Haghpanah S, Karimi M.

Fonte‎: Hematology 2018;23(7):417-22.

Indexado‎: PubMed 29157136

DOI‎: 10.1080/10245332.2017.1404262

https://www.ncbi.nlm.nih.gov/pubmed/29157136 (abre nova janela)

Cost-effectiveness of hydroxyurea in reducing the frequency of pain episodes and hospitalization in pediatric sickle cell disease. (abre nova janela)

Stallworth JR, Jerrell JM, Tripathi A.

Fonte‎: Am J Hematol 2010;85(10):795-7.

Indexado‎: PubMed 20645429

DOI‎: 10.1002/ajh.21772

https://www.ncbi.nlm.nih.gov/pubmed/20645429 (abre nova janela)

HEMATOLOGIA E ONCOLOGIA

Economias de custo

Português (Brasil)

Economias de custo

/assets/ct/fa66d95d54/images/syn_placeholder_sqr.png

Abordagem sistemática e multimodal

Impact of a patient blood management monitoring and feedback programme on allogeneic blood transfusions and related costs. (abre nova janela)

Cost-effectiveness of eltrombopag vs intravenous immunoglobulin for the perioperative management of immune thrombocytopenia. (abre nova janela)

Blood use in patients receiving intensive chemotherapy for acute leukemia or hematopoietic stem cell transplantation: the impact of a health system-wide patient blood management program. (abre nova janela)

Implementation of a patient blood management monitoring and feedback program significantly reduces transfusions and costs. (abre nova janela)

Prospective monitoring of plasma and platelet transfusions in a large teaching hospital results in significant cost reduction. (abre nova janela)

Anemia Management

Should intravenous iron be the standard of care in oncology? (abre nova janela)

Early intravenous iron administration in the Emergency Department reduces red blood cell unit transfusion, hospitalisation, re-transfusion, length of stay and costs. (abre nova janela)

The cost-effectiveness of treatment with erythropoietin compared to red blood cell transfusions for patients with chemotherapy induced anaemia: a Markov model. (abre nova janela)

Hemoglobin level at initiation of darbepoetin alfa: impact on need for transfusion and associated costs in chemotherapy-induced anemia treatment in Europe. (abre nova janela)

Prospective study of erythropoietin use on quality of life and cost effectiveness in acute myeloid leukemia and allogeneic hematopoietic stem cell transplantation patients. (abre nova janela)

Budget impact analysis on erythropoiesis-stimulating agents use for the management of chemotherapy-induced anaemia in Greece. (abre nova janela)

Outcomes of erythropoiesis-stimulating agents in cancer patients with chemotherapy-induced anemia. (abre nova janela)

Agentes hemostáticos

Modeling the cost-effectiveness of prothrombin complex concentrate compared with fresh frozen plasma in emergency warfarin reversal in the United Kingdom. (abre nova janela)

Recombinant activated factor VII use in critically ill infants with active hemorrhage. (abre nova janela)

Manejo do sangue e conservação do sangue intraoperatório/periprocedimento

Restrictive blood transfusion practices are associated with improved patient outcomes. (abre nova janela)

Blood transfusion versus hydroxyurea in beta-thalassemia in Iran: a cost-effectiveness study. (abre nova janela)

Cost-effectiveness of hydroxyurea in reducing the frequency of pain episodes and hospitalization in pediatric sickle cell disease. (abre nova janela)

Comissão de Ligação com Hospitais (Colih)

Conteúdos para baixar

Vídeos

Economias de custo

Abordagem sistemática e multimodal

Anemia Management

Agentes hemostáticos

Manejo do sangue e conservação do sangue intraoperatório/periprocedimento

Selecione seu idioma